Eagle Genomics Gains Microsoft Co-Sell Status for Microbiome Mapping AI Platform
Crescendo Biologics Strenghthens its Management team
Using Public Money to Leverage Private Finance into our Portfolio
We have leveraged £200+ million of private investment to create more than 40 companies.
Astellas Announces Acquisition of Quethera
UKI2S announces seed investment in Cagen
CellCentric raises $26m for new late-state prostate cancer drug
If you think you meet our investment criteria then please get in touch using the form below
... the UK Minstry of Defence (MoD) through the Defence Science and Technology Laboratory...
Peter's is the first spin-out from the James Hutton Institute to secure a Converge...